Dole (NYSE:DOLE) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Speaker3Welcome to Dole plc's fourth quarter and full year 2025 results webcast. Today's webcast is being broadcast live over the internet and is also being recorded for playback purposes. Currently, all participants are in listen-only mode. After the speakers' presentations, there will be a question and answer session. For opening remarks and introductions, I would like to send the call over to the Head of Investor Relations with Dole plc ...

依据恒生指数有限公司检讨结果，本公司还将获选纳入多项恒生指数系列成份股，包括恒生综合中小型 股指数、恒生综合小型股指数、恒生小型股(可投资)指数、恒生港股通中国内地公司指数、恒生港股通 中小型股指数、恒生港股通小型股指数、恒生港股通创新药指数、恒生港股通创新药精选指数、恒生港 股通药品及生物技术(可投资)指数、恒生综合行业指数 - 医疗保健业、恒生医疗保健指数。 董事会认为，此次公司股票获选纳入多项重要指数，体现投资者对公司价值与成长潜力的认可，预期将 提升公司股票流动性、扩大持股人群、增加股东类型的多样性，有利于公司的长远稳定发展。董事会谨 此感谢股东及投资者的持续支持，本公司将深化在RAS赛道的领先优势及其他创新药领域的国际竞争 力，以深耕的研发优势驱动与时俱进的产业价值创造，实现市场开拓与社会责任的协同共赢。 智通财经APP讯，劲方医药-B(02595)发布公告，依据恒生指数有限公司于2026年2月13日公布的恒生指 数系列季度检讨结果，本公司入选恒生综合指数(HSCI)、恒生港股通指数以及恒生创新药指数等系列成 分股。该调整将于2026年3月9日正式生效。此外，摩根士丹利资本国际指数(MSCI)近日宣 ...

作为IPO计划的一部分，SpaceX希望绕过传统规则，以便更早地为股东带来流动性。据知情人士透露， SpaceX顾问已提议修改指数纳入政策，以便公司能够更快地被纳入主要指数，此举也可能惠及其他高 估值的私营企业。 SpaceX此前的估值为8000亿美元(收购xAI之前)，目标是在IPO时实现超过1万亿美元的估值。若成功上 市，它将成为美国历史上规模最大的IPO。有投行人士指出，SpaceX、AI创业公司OpenAI与Anthropic 预计最快将于今年上市，这可能成为IPO市场的一个高光时期。对于这些即将公开交易的公司而言，建 立稳定的投资者基础对其长期成功至关重要。(作者/箫雨) 凤凰网科技讯 北京时间2月5日，据《华尔街日报》报道，埃隆·马斯克(Elon Musk)旗下SpaceX正寻求在 今年晚些时候首次公开招股(IPO)后，尽早推动股价上涨。 据知情人士透露，SpaceX已接洽包括纳斯达克在内的主要指数供应商，商讨如何让SpaceX以及今年其 他热门上市创业公司以比平时更快的速度被纳入关键指数。 通常情况下，企业上市后需等待数月乃至一年，才有资格被纳入标普500或纳斯达克100等主要指数。一 旦被纳入 ...

埃隆.马斯克的火箭-卫星公司SpaceX准备在登陆股市后，尽早为其股票带来一波提振。据知情人士透 露，这家最近与xAI合并的公司的顾问已接触包括纳斯达克(Nasdaq)在内的主要指数提供商，讨论 SpaceX和今年其他热门初创公司如何能比通常更快地被纳入关键指数。公司通常必须在上市后等待数 月或一年，才能被纳入标普500指数或纳斯达克100指数等主要指数。被纳入指数可以开启获取基金的散 户和机构资金的通道，尤其是那些跟踪指数表现、因而必须持有指数成分股的基金。传统的等待期旨在 让公司有时间证明，它们足够稳定且流动性充足，能够应对来自指数基金的大量买盘。作为其计划中 IPO的一部分，SpaceX希望规避传统规则，以便尽早为其股东带来流动性。这些知情人士称，SpaceX的 顾问已寻求改变指数政策，以便让该公司能被快速纳入主要指数，并惠及其他高估值的非上市公司。 SpaceX最新估值为8,000亿美元，目标估值超过1万亿美元，若成功上市，将成为美国有史以来规模最大 的IPO。 来源：滚动播报 ...

Core Viewpoint - 易鑫集团's stock price increased by over 7% towards the end of trading, reflecting positive market sentiment following the announcement of a renewed strategic cooperation agreement with 精真估 for used car services [1] Group 1: Strategic Developments - 易鑫集团 announced a three-year renewal of its strategic cooperation agreement with 精真估, which will continue to provide used car valuation and related services [1] - The annual service fee cap under the existing agreement was raised from 50 million to 60 million yuan, indicating the company's confidence in the growing demand for used car services [1] Group 2: Market Position and Performance - 易鑫集团 is a subsidiary of Tencent, and the deepening collaboration with Tencent is expected to enhance the company's market position [1] - The company was included in the newly launched Hong Kong Stock Exchange Technology 100 Index, which is anticipated to improve its liquidity [1] - Q3 operational data showed growth rates exceeding market expectations, suggesting that the company is likely to maintain high growth for the full year [1]

Group 1 - UiPath will join the S&P MidCap 400 Index, replacing Synovus Financial, with the change effective prior to trading on Friday [1][5] - The inclusion in the index is viewed as a bullish signal, potentially attracting new investors and funds that track the index [2][4] - UiPath shares increased approximately 5% in recent trading and have gained about 30% in value this year [4] Group 2 - S&P Dow Jones Indices also announced that Versant Media Group will replace Brandywine Realty Trust in the S&P SmallCap 600 Index, effective January 6 [3][5] - Comcast will remain in the S&P 500 Index despite the changes to the SmallCap 600 [3]

Group 1 - U.S. stock futures were mostly flat, with Nasdaq 100 futures slipping around 0.01% [1] - Sidus Space, Inc. announced a public offering of 19,230,800 shares at $1.30 per share, leading to a 39.2% decline in its shares to $1.39 in pre-market trading [1] Group 2 - Starfighters Space Inc shares dipped 23.2% to $24.19 after a significant gain of over 370% on Monday [2] - ECD Automotive Design, Inc. fell 15.4% to $0.1650 following a 1-for-5 reverse stock split announcement [2] - CapsoVision Inc dipped 5.6% to $12.35, while Rocket Lab Corp fell 5.3% to $73.46 after a previous 10% jump [2] - Intuitive Machines Inc declined 5.2% to $15.82 despite a price target increase from $14 to $20 by B. Riley Securities [2] - Firefly Aerospace Inc shares declined 4.4% to $27.33 after a 16% increase due to joining the Russell 2000 and Russell 3000 indexes [2] - AST SpaceMobile Inc shares declined 3.1% to $83.82 after a 14% surge related to new satellite details [2]

Core Viewpoint - UBS reports that Innovent Biologics (01801) has six new products and a new indication for sintilimab included in the latest National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025) [1] - Innovent Biologics has been officially included in the Hang Seng Index as of today [1] - UBS maintains a "Buy" rating with a target price of HKD 137.4 [1] Group 1 - The new products targeting IGF-1R, EGFR, BTK, ROS1, KRAS G12C, and RET are expected to see rapid sales growth by 2026 [1] - The inclusion of teriparatide for diabetes in the insurance list positively impacts the expected launch of masitinib in 2026, although price adjustments need to be monitored [1] - Inclusion in the Hang Seng Index is anticipated to further enhance liquidity for the company's stock [1]

Group 1 - The core point of the article is that China Hongqiao (1378.HK) saw its stock price rise over 4% to HKD 34.32 following the announcement of its inclusion in the FTSE China 50 Index by FTSE Russell [1] Group 2 - FTSE Russell announced the quarterly review results for the FTSE China Index Series, with all changes effective from December 22, 2025 [1] - China Hongqiao's inclusion in the FTSE China 50 Index is a significant development for the company, potentially enhancing its visibility and attractiveness to investors [1]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a potential relative price increase of over 15% [16]. Core Insights - The company has announced a share buyback plan with a total amount between 300 million to 500 million RMB, aimed at reducing registered capital by canceling the repurchased shares [2][3]. - The company has been included in the CSI A500 Index, which is expected to enhance its visibility and attract more investments from index funds [3][8]. - The construction of the Haizetang coal mine is progressing steadily, with expectations to begin trial production in July 2026, which is anticipated to significantly improve the company's operational performance [3][9]. Summary by Sections Share Buyback Plan - The company plans to repurchase shares at a maximum price of 2.5 RMB per share, with the buyback period lasting 12 months from the approval date by the shareholders [2][3]. - The estimated number of shares to be repurchased ranges from 120 million to 200 million, accounting for approximately 0.55% to 0.92% of the total share capital [3]. Index Inclusion - The company has been added to the CSI A500 Index, which has a total scale of 195.401 billion RMB, and index funds related to this index are expected to rebalance around December 15, potentially leading to increased holdings in the company [3][8]. Haizetang Coal Mine Project - The Haizetang coal mine is expected to produce high-quality coal with a calorific value of over 6500 kcal and low extraction costs, projected to generate an additional annual revenue of approximately 6.5 billion RMB and a net profit of around 3 billion RMB once fully operational [9]. - The company forecasts net profits of 316 million RMB, 854 million RMB, and 1.558 billion RMB for the years 2025 to 2027, respectively, with corresponding EPS of 0.01 RMB, 0.04 RMB, and 0.07 RMB [10].